title: A volatile time for British drug policies: commentary on the editorial by Alan Glanz.
authors.forename: G V
authors.initials: GV
authors.lastname: Stimson
authors.forename: M
authors.initials: M
authors.lastname: Donoghoe
authors.forename: K
authors.initials: K
authors.lastname: Dolan
authors.forename: L
authors.initials: L
authors.lastname: Alldritt
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D006291:Health Policy / Q000639:trends*; D006556:Heroin Dependence / Q000150:complications* / Q000517:prevention & control; D006801:Humans; D012307:Risk Factors; D006113:United Kingdom